BCRX Insider Trading

Insider Ownership Percentage: 4.80%
Insider Buying (Last 12 Months): $596,337.56
Insider Selling (Last 12 Months): $82,486.00

BioCryst Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at BioCryst Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioCryst Pharmaceuticals Share Price & Price History

Current Price: $7.60
Price Change: Price Increase of +0.11 (1.47%)
As of 11/22/2024 01:00 AM ET

This chart shows the closing price history over time for BCRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BioCryst Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/24/2024Amy E MckeeDirectorSell8,600$6.32$54,352.0027,831View SEC Filing Icon  
6/17/2024Machelle SandersDirectorSell4,689$6.00$28,134.0027,742View SEC Filing Icon  
5/30/2024Alan G LevinDirectorBuy7,861$6.36$49,995.9644,951View SEC Filing Icon  
5/24/2024Steve AselageDirectorBuy2,500$6.40$16,000.002,500View SEC Filing Icon  
5/20/2024Nancy J. HutsonDirectorBuy5,000$6.38$31,900.0086,818View SEC Filing Icon  
5/14/2024Anthony DoyleCFOBuy36,300$5.57$202,191.00266,744View SEC Filing Icon  
5/14/2024Helen M ThackrayInsiderBuy30,000$5.86$175,800.00272,139View SEC Filing Icon  
5/13/2024Steven K GalsonDirectorBuy21,940$5.49$120,450.6051,551View SEC Filing Icon  
6/15/2023Machelle SandersDirectorSell4,000$7.98$31,920.0025,611View SEC Filing Icon  
2/1/2023Jon P. StonehouseCEOSell100,000$10.38$1,038,000.001,008,739View SEC Filing Icon  
12/15/2022Anthony DoyleCFOSell5,700$10.90$62,130.00163,966View SEC Filing Icon  
12/15/2022Helen M ThackrayInsiderSell3,125$10.89$34,031.25133,275View SEC Filing Icon  
12/15/2022Jon P. StonehouseCEOSell14,100$10.90$153,690.00887,730View SEC Filing Icon  
12/15/2022Michael L JonesDirectorSell445$10.90$4,850.5010,753View SEC Filing Icon  
12/2/2022Jon P. StonehouseCEOSell82,656$12.80$1,057,996.80901,830View SEC Filing Icon  
12/1/2022Michael L JonesDirectorSell8,600$13.01$111,886.0011,198View SEC Filing Icon  
11/14/2022Yarlagadda S. BabuInsiderSell31,515$13.88$437,428.20298,541View SEC Filing Icon  
4/1/2022Helen M ThackrayInsiderSell7,600$16.20$123,120.00136,400View SEC Filing Icon  
2/15/2022George B. AbercrombieDirectorSell5,000$18.50$92,500.00View SEC Filing Icon  
1/11/2022Jon P. StonehouseCEOSell184,000$15.04$2,767,360.00View SEC Filing Icon  
12/7/2021Yarlagadda S. BabuInsiderSell30,100$12.20$367,220.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

85.88% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioCryst Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/21/2024SkyView Investment Advisors LLC13,000$99K0.0%+30.0%0.006%Search for SEC Filing on Google Icon
11/18/2024Arete Wealth Advisors LLC12,050$92K0.0%-45.7%0.006%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC4,837,985$36.78M0.0%+2.7%2.336%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd83,123$0.63M0.0%-7.0%0.040%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd31,670$0.24M0.0%-79.8%0.015%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP107,820$0.82M0.0%N/A0.052%Search for SEC Filing on Google Icon
11/15/2024Two Sigma Advisers LP2,181,012$16.58M0.0%+13.6%1.053%Search for SEC Filing on Google Icon
11/15/2024State Street Corp8,849,588$67.26M0.0%-5.3%4.272%Search for SEC Filing on Google Icon
11/15/2024Quantinno Capital Management LP10,731$82K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC464,048$3.53M0.5%+15.9%0.224%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.367,514$2.79M0.0%-50.3%0.177%Search for SEC Filing on Google Icon
11/15/2024Cinctive Capital Management LP273,959$2.08M0.1%N/A0.132%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH40,000$0.31M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/14/2024Caligan Partners LP2,583,585$19.64M6.2%-43.8%1.247%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC522,280$3.97M0.4%+42.4%0.252%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC39,520$0.30M0.0%-72.2%0.019%Search for SEC Filing on Google Icon
11/14/2024Captrust Financial Advisors16,274$0.12M0.0%+19.4%0.008%Search for SEC Filing on Google Icon
11/14/2024Rockefeller Capital Management L.P.26,400$0.20M0.0%N/A0.013%Search for SEC Filing on Google Icon
11/14/2024Alkeon Capital Management LLC7,093,822$53.91M0.1%-0.1%3.425%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC389,530$2.96M0.0%-10.0%0.188%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank 51,012$0.39M0.0%+7.7%0.025%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets496,784$3.78M0.0%+472.0%0.240%Search for SEC Filing on Google Icon
11/13/2024FMR LLC1,988,389$15.11M0.0%+2.4%0.960%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 299,152$2.27M0.0%+40.7%0.144%Search for SEC Filing on Google Icon
11/13/2024Dynamic Technology Lab Private Ltd11,352$86K0.0%-71.7%0.005%Search for SEC Filing on Google Icon
11/13/2024Fisher Asset Management LLC3,338,062$25.37M0.0%+16.9%1.612%Search for SEC Filing on Google Icon
11/12/2024Alpha DNA Investment Management LLC58,898$0.45M0.2%N/A0.028%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC516,209$3.92M0.1%+46.2%0.249%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.1,887,994$14.35M0.0%+5.8%0.912%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC54,237$0.41M0.0%N/A0.026%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.682,324$5.19M0.0%-12.8%0.330%Search for SEC Filing on Google Icon
11/8/2024Segall Bryant & Hamill LLC1,490,376$11.33M0.2%-2.4%0.720%Search for SEC Filing on Google Icon
11/8/2024Counterweight Ventures LLC93,384$0.71M0.5%+591.7%0.045%Search for SEC Filing on Google Icon
11/6/2024KBC Group NV5,661$43K0.0%-34.4%0.003%Search for SEC Filing on Google Icon
11/5/2024Aigen Investment Management LP28,661$0.22M0.0%+75.0%0.014%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP285,588$2.17M0.2%-21.5%0.138%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC86,533$0.66M0.0%-11.3%0.042%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.411,414$3.13M0.0%+1,058.1%0.199%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC2,163,743$16.44M0.9%+4.0%1.048%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.39,791$0.30M0.0%+64.1%0.019%Search for SEC Filing on Google Icon
10/24/2024Semanteon Capital Management LP149,576$1.14M0.8%N/A0.072%Search for SEC Filing on Google Icon
10/24/2024Wealth Enhancement Advisory Services LLC17,344$0.13M0.0%+44.5%0.008%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.7,483$57K0.0%+21.5%0.004%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.14,071$0.11M0.0%-78.3%0.007%Search for SEC Filing on Google Icon
10/16/2024nVerses Capital LLC15,500$0.12M0.1%+52.0%0.008%Search for SEC Filing on Google Icon
10/11/2024Creative Planning49,347$0.38M0.0%+5.9%0.024%Search for SEC Filing on Google Icon
10/10/2024Inspire Investing LLC158,008$1.20M0.1%+174.6%0.077%Search for SEC Filing on Google Icon
10/8/2024CWM LLC17,072$0.13M0.0%+201.7%0.008%Search for SEC Filing on Google Icon
10/7/2024Diversified Trust Co21,680$0.17M0.0%-12.4%0.011%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC158,921$1.21M0.0%N/A0.077%Search for SEC Filing on Google Icon
9/5/2024Sanctuary Advisors LLC26,571$0.16M0.0%N/A0.013%Search for SEC Filing on Google Icon
8/16/2024Northeast Financial Consultants Inc65,633$0.41M0.0%+8.2%0.032%Search for SEC Filing on Google Icon
8/16/2024Creative Planning46,613$0.29M0.0%+75.2%0.023%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC353,133$2.18M0.1%+18.6%0.171%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Fundamental Investments LLC30,176$0.19M0.0%-53.1%0.015%Search for SEC Filing on Google Icon
8/15/2024Mackenzie Financial Corp27,913$0.17M0.0%-13.5%0.014%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company212,581$1.31M0.0%+113.8%0.103%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC1,751,561$10.83M0.0%-13.8%0.849%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C8,135,804$50.28M0.8%+62.9%3.942%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC543,241$3.36M0.0%+18.8%0.263%Search for SEC Filing on Google Icon
8/15/2024ELCO Management Co. LLC30,792$0.19M0.1%-14.5%0.015%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.72,666$0.45M0.1%N/A0.035%Search for SEC Filing on Google Icon
8/15/2024Point72 Europe London LLP267,649$1.65M0.1%N/A0.130%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC1,112,232$6.87M0.0%+528.0%0.538%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd66,564$0.41M0.0%+598.2%0.032%Search for SEC Filing on Google Icon
8/14/2024Xponance Inc.12,980$80K0.0%+13.1%0.006%Search for SEC Filing on Google Icon
8/14/2024Avoro Capital Advisors LLC12,570,000$77.68M1.0%-3.7%6.091%Search for SEC Filing on Google Icon
8/14/2024DRW Securities LLC11,987$74K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC38,128$0.24M0.0%-21.4%0.018%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC86,815$0.54M0.0%-64.1%0.042%Search for SEC Filing on Google Icon
8/12/2024Inspire Investing LLC57,550$0.36M0.0%-17.2%0.028%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd156,946$0.97M0.1%+299.0%0.076%Search for SEC Filing on Google Icon
8/12/2024Seven Eight Capital LP169,612$1.05M0.1%+1,407.1%0.082%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC125,004$0.76M0.0%+32.7%0.061%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.28,285$0.18M0.0%-61.9%0.014%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC960,180$5.93M0.0%-39.6%0.465%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.148,490$0.92M0.0%+896.6%0.072%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC2,079,641$12.85M0.8%-3.3%1.008%Search for SEC Filing on Google Icon
8/7/2024Headlands Technologies LLC16,750$0.10M0.0%N/A0.008%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC97,577$0.60M0.0%+8.9%0.047%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc240,600$1.49M0.0%N/A0.117%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers318,665$1.97M0.0%+6.3%0.154%Search for SEC Filing on Google Icon
7/31/2024nVerses Capital LLC10,200$63K0.0%N/A0.005%Search for SEC Filing on Google Icon
7/31/2024Commonwealth Equity Services LLC143,874$0.89M0.0%-1.0%0.070%Search for SEC Filing on Google Icon
7/30/2024Signaturefd LLC6,598$41K0.0%+560.5%0.003%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.35,524$0.22M0.0%-26.3%0.017%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.650,318$4.02M0.0%+2.8%0.315%Search for SEC Filing on Google Icon
7/27/2024Leisure Capital Management28,000$0.17M0.1%N/A0.014%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp775,957$4.80M0.0%+12.5%0.376%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.64,907$0.40M0.0%-83.2%0.031%Search for SEC Filing on Google Icon
7/16/2024Diversified Trust Co24,752$0.15M0.0%+18.0%0.012%Search for SEC Filing on Google Icon
7/10/2024CWM LLC5,658$35K0.0%+200.0%0.003%Search for SEC Filing on Google Icon
5/17/2024Tidal Investments LLC55,560$0.28M0.0%N/A0.027%Search for SEC Filing on Google Icon
5/16/2024Redwood Investment Management LLC122,270$0.62M0.1%N/A0.059%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System184,788$0.94M0.0%-7.6%0.090%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.156,119$0.79M0.0%+62.0%0.076%Search for SEC Filing on Google Icon
5/16/2024Kynam Capital Management LP6,527,491$33.16M3.5%+41.9%3.163%Search for SEC Filing on Google Icon
5/15/2024Sarissa Capital Management LP1,094,168$5.56M1.0%+9.4%0.530%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD130,775$0.67M0.0%+15.0%0.063%Search for SEC Filing on Google Icon
5/14/2024Nan Fung Group Holdings Ltd36,847$0.19M0.2%+106.5%0.018%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Read More on BioCryst Pharmaceuticals

Today's Range

Now: $7.60
Low: $7.42
High: $7.66

50 Day Range

MA: $7.66
Low: $7.03
High: $8.43

52 Week Range

Now: $7.60
Low: $4.03
High: $8.88

Volume

1,977,442 shs

Average Volume

2,477,516 shs

Market Capitalization

$1.57 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.89

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals' top insider shareholders include:
  1. Jon P Stonehouse (CEO)
  2. Helen M Thackray (Insider)
  3. Anthony Doyle (CFO)
  4. Nancy J Hutson (Director)
  5. Steven K Galson (Director)
  6. Alan G Levin (Director)
  7. Amy E Mckee (Director)
  8. Machelle Sanders (Director)
  9. Michael L Jones (Director)
  10. Steve Aselage (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.

Who are the major institutional investors of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals' top institutional shareholders include:
  1. State Street Corp — 4.27%
  2. Alkeon Capital Management LLC — 3.42%
  3. Geode Capital Management LLC — 2.34%
  4. Fisher Asset Management LLC — 1.61%
  5. Caligan Partners LP — 1.25%
  6. Two Sigma Advisers LP — 1.05%
Learn More about top institutional investors of BioCryst Pharmaceuticals stock.

Which major investors are selling BioCryst Pharmaceuticals stock?

During the last quarter, BCRX stock was sold by these institutional investors:
  1. Caligan Partners LP
  2. State Street Corp
  3. Jane Street Group LLC
  4. Jacobs Levy Equity Management Inc.
  5. XTX Topco Ltd
  6. Verition Fund Management LLC
  7. Connor Clark & Lunn Investment Management Ltd.
  8. GSA Capital Partners LLP
Within the previous year, company insiders that have sold BioCryst Pharmaceuticals company stock include:
  1. Jon P Stonehouse (CEO)
  2. Helen M Thackray (Insider)
Learn More investors selling BioCryst Pharmaceuticals stock.

Which major investors are buying BioCryst Pharmaceuticals stock?

Within the previous quarter, BCRX stock was bought by institutional investors including:
  1. Fisher Asset Management LLC
  2. BNP Paribas Financial Markets
  3. Principal Financial Group Inc.
  4. Cinctive Capital Management LP
  5. Two Sigma Advisers LP
  6. Algert Global LLC
  7. SG Americas Securities LLC
  8. PDT Partners LLC
In the previous year, these company insiders have bought BioCryst Pharmaceuticals stock:
  1. Jon P Stonehouse (CEO)
  2. Helen M Thackray (Insider)
  3. Anthony Doyle (CFO)
  4. Nancy J Hutson (Director)
  5. Steven K Galson (Director)
  6. Alan G Levin (Director)
Learn More investors buying BioCryst Pharmaceuticals stock.